First human tests begin for new pill
NCT ID NCT06970301
Summary
This is an early-stage study to check the safety and how the body processes a new oral drug called UCB0022 (glovadalen). It will involve 32 healthy adult volunteers from Caucasian, Japanese, and Chinese backgrounds. The main goal is to see what side effects occur and how the drug moves through the body at different doses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY STUDY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Up0135 1001
RECRUITINGGlendale, California, 91206, United States
Conditions
Explore the condition pages connected to this study.